- Home
- PEN vs JLL Comparison
PEN vs JLL Comparison
Compare PEN & JLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEN
- JLL
- Stock Information
- Founded
- PEN 2004
- JLL 1997
- Country
- PEN United States
- JLL United States
- Employees
- PEN N/A
- JLL N/A
- Industry
- PEN Medical/Dental Instruments
- JLL Real Estate
- Sector
- PEN Health Care
- JLL Finance
- Exchange
- PEN Nasdaq
- JLL Nasdaq
- Market Cap
- PEN 10.5B
- JLL 10.4B
- IPO Year
- PEN 2015
- JLL 1997
- Fundamental
- Price
- PEN $297.46
- JLL $229.64
- Analyst Decision
- PEN Strong Buy
- JLL Strong Buy
- Analyst Count
- PEN 16
- JLL 6
- Target Price
- PEN $299.73
- JLL $315.83
- AVG Volume (30 Days)
- PEN 543.6K
- JLL 371.8K
- Earning Date
- PEN 04-23-2025
- JLL 05-07-2025
- Dividend Yield
- PEN N/A
- JLL N/A
- EPS Growth
- PEN N/A
- JLL 78.40
- EPS
- PEN 1.08
- JLL 11.07
- Revenue
- PEN $1,240,100,000.00
- JLL $24,054,800,000.00
- Revenue This Year
- PEN $14.26
- JLL $9.68
- Revenue Next Year
- PEN $14.21
- JLL $7.67
- P/E Ratio
- PEN $277.28
- JLL $20.77
- Revenue Growth
- PEN 13.17
- JLL 13.63
- 52 Week Low
- PEN $148.00
- JLL $186.50
- 52 Week High
- PEN $310.00
- JLL $288.50
- Technical
- Relative Strength Index (RSI)
- PEN 60.78
- JLL 50.82
- Support Level
- PEN $285.27
- JLL $220.00
- Resistance Level
- PEN $296.44
- JLL $232.82
- Average True Range (ATR)
- PEN 10.39
- JLL 6.69
- MACD
- PEN 0.15
- JLL 2.05
- Stochastic Oscillator
- PEN 70.40
- JLL 73.56
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.
About JLL Jones Lang LaSalle Incorporated
Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $74 billion for clients across diverse public and private real estate strategies.